Nadeem Mirza, MD
Psychiatry · Paw Paw, MINPI 1437159597
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $644 of the $756 with a category attached, or 85.3%. 8 manufacturers reported payments, led by Eisai Inc. at 29.4% of the total. Reporting peaked in 2024 at $262 and has fallen 75.2% since, to $65 in 2025.
Across 16 payments — averaging $47.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$222
- Teva Pharmaceuticals USA, Inc.$208
- Axsome Therapeutics, Inc.$120
- Neurocrine Biosciences, Inc.$75
- Idorsia Pharmaceuticals US Inc$66
- Otsuka America Pharmaceutical, Inc.$28
- plus $36 from 2 others
Across 14 payments — averaging $1594.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$14K
- Janssen Research & Development, LLC$8K
- Avanir Pharmaceuticals, Inc.$1K
What the payments were for
- Food & beverage$64485%
- Education$11115%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 7 | $222 |
| Teva Pharmaceuticals USA, Inc. | 3 | $208 |
| Axsome Therapeutics, Inc. | 1 | $120 |
| Neurocrine Biosciences, Inc. | 1 | $75 |
| Idorsia Pharmaceuticals US Inc | 1 | $66 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| AstraZeneca | 1 | $20 |
| Lundbeck LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$756 in reported general payments places this provider in the 70th percentile of 1,166 psychiatry providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 265 | $6,582 |
| Donepezil Hcl | 252 | $3,211 |
| Sertraline Hcl | 142 | $1,356 |
| Aripiprazole | 38 | $1,350 |
| Buspirone Hcl | 61 | $870 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 11 | $843 |
| Mirtazapine | 52 | $703 |
| Memantine Hcl ErMemantine Hcl | 18 | $648 |
| Divalproex Sodium | 17 | $425 |
| Bupropion XlBupropion Hcl | 21 | $416 |
| Quetiapine Fumarate | 47 | $412 |
| Duloxetine Hcl | 12 | $363 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 28 | $322 |
| Escitalopram Oxalate | 28 | $299 |
| Fluoxetine Hcl | 16 | $252 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Paw Paw
- Andreas SidiropoulasDetroit$2.8M
- Welton WashingtonYpsilanti$1.4M
- Joel YoungRochester Hills$1.1M
- Manzar RajputMonroe$612K
- William GuySouthfield$562K
- Robert LagrouClarkston$267K
- Michael IngramBay City$255K
- Samuel WedesLivonia$158K
- Arash JavanbakhtDetroit$102K
- Theodore RuzaWest Bloomfield$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.